Archer Daniels' Pain May Be Investors' Gain

Business is solid, despite legal problems sinking the stock

Long-suffering shareholders of Archer-Daniels-Midland Co., having endured embarrassing revelations of alleged corporate misconduct, are bracing for another trip to the woodshed. In September, the U.S. Justice Dept. expects to bring price-fixing charges involving the animal-feed ingredient lysine against ADM and two key executives. A month later, the grain and oilseed processor is likely to unveil weak earnings due to steep commodity prices. And on Oct. 17, reform activistists are poised to vent complaints about corporate governance at ADM's annual meeting.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.